PIA
PDLI

Peachtree Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Peachtree Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,400
Closed -$18K – 399
2014
Q3 		$18K Buy
+2,400
New +$22.3K 0.01% 272

Other funds holding PDLI

ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Peachtree Investment Advisors's PDLI Position: Q4 2014 in Review

Peachtree Investment Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 2,400 shares — an estimated $18K sold.

Peachtree Investment Advisors first reported a position in PDLI in Q3 2014 and held it in 1 quarter. The position peaked at $18K in Q3 2014. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

  • Peachtree Investment Advisors reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
  • Peachtree Investment Advisors sold 2,400 PDL BioPharma, Inc. shares in Q4 2014, an estimated $18K.
  • Peachtree Investment Advisors first reported a position in PDL BioPharma, Inc. in Q3 2014 and held it in 1 quarter.
  • Peachtree Investment Advisors's PDL BioPharma, Inc. position peaked at $18K in Q3 2014.
  • 223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on Peachtree Investment Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.